Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT03605953 · UNKNOWN
Trial details
- NCT number
- NCT03605953
- Sponsor
- Central Hospital, Nancy, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-01
- Primary completion
- 2019-10-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.